Results 131 to 140 of about 14,183,490 (208)

The Role of Outcome Response Rate in Planning Biosimilar Studies Using Different Evaluation Metrics. [PDF]

Pharmaceuticals (Basel)
Cen L, Arani R, Tang D.
europepmc   +1 more source

Neoadjuvant or conversion anti-PD-1/PD-L1 immunotherapy combined with chemotherapy improves 2-year survival and achieves high pathological complete response rate in patients with stage IIB-IIIB small-cell lung cancer. [PDF]

Transl Lung Cancer Res
Gao Z, Li Z, Yao X, Shao C, Chen J, Fan Z, Zhao J, Wang J, Ni Y, Xing M, Yan X.   +10 more
europepmc   +1 more source

The MHC-I-dependent neoantigen presentation pathway predicts response rate to PD-1/PD-L1 blockade. [PDF]

Biomol Biomed
Zhang Y, Yang C, Xu Y, Jiang X, Shi J, Li B, Yu D.   +6 more
europepmc   +1 more source

Factors associated with placebo response rate in randomized controlled trials of antiseizure medications for focal epilepsy. [PDF]

Epilepsia
Kerr WT, Suprun M, Kok N, Reddy AS, McFarlane KN, Kwan P, Somerville E, Bagiella E, French JA.   +8 more
europepmc   +1 more source

Response Rate to the Intervention with Tirbanibulin 1% Ointment for Treating Actinic Keratoses in People Living with HIV Infection. [PDF]

Diagnostics (Basel)
Ciccarese G, Drago F, Lospalluti L, Grandolfo M, Lo Caputo S, Mastrolonardo M, Tirone B, Castronovi C, Bortone R, Cazzato G, Foti C.   +10 more
europepmc   +1 more source

Evaluation of response characteristic of rate responsive pacemaker by physical activity rate.

Jinko Zoki, 1986
TOYOSHIMA, T., TOGAWA, T., TSUJI, T, SUMA, K.   +3 more
openaire   +1 more source

Response Rate Correlates with the Conversion Rate in Patients with Advanced Hepatocellular Carcinoma Treated with Systemic or Hepatic Artery Infusion Chemotherapy: A Systematic Review.

Dig Surg
Okuno M, Nishino H, Okura K, Ishii T, Hashida H, Hatano E.   +5 more
europepmc   +1 more source

Short Course Brachytherapy in Locally Advanced Cervical Cancer; Safety and Response Rate. [PDF]

Asian Pac J Cancer Prev
Aghili M, Babaei M, Bayani R, Jaberi R, Amouzegar Hashemi F, Kalaghchi B, Rezaei S, Jafari F, Vand Rajabpour M, Garousi S, Garousi M.   +10 more
europepmc   +1 more source

ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial. [PDF]

NPJ Precis Oncol
Herzog TJ, Krivak TC, Bush S, Diaz JP, Lentz S, Nair N, Zgheib NB, Gunderson-Jackson C, Barve A, Denning KL, Lirette ST, Howard CM, Valluri J, Claudio PP.   +13 more
europepmc   +1 more source

Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumab. [PDF]

Transl Androl Urol
Hashimoto M, Fukiage K, Taniguchi K, Minami T, Fukuokaya W, Mori K, Yanagisawa T, Tsujino T, Maenosono R, Saruta M, Takahara K, Hashimoto T, Hirasawa Y, Azuma H, Ohno Y, Shiroki R, Fujita K, behalf of ULTRA-J group.   +17 more
europepmc   +1 more source